San Francisco, January 8th through 11th at the J.P. Morgan Healthcare Conference. Anavex is attending the 36th annual J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry.
Efficacy of ANAVEX 2-73, a Sigma-1 receptor agonist, in the MECP2 mouse model of Rett syndrome
Anavex Life Sciences will be presenting data at the CTAD conference in Boston, Massachusetts on Saturday November 4th at 3:30 PM.
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017
Anavex Life Sciences will be presenting at 11am this year at the OktoberINVESTfest. The day long event will be held at the New York Academy of Sciences on 250 Greenwich Street in New York City from 8am to 6pm.
Anavex Life Sciences will be presenting at the Ladenburg Thalmann 2017 Healthcare Conference on Sept 26 at 3:30pm in New York, NY at the Sofitel Hotel.
Anavex Life Sciences will be presenting at the CNS Diseases Summit 2017 from Sept 11-12 in Boston, Massachusetts at the Hyatt Regency Boston.
Anavex Life Sciences will be attending the Bio International Convention from June 19th to 22nd in San Diego, California at the San Diego Convention Center.